News
Eli Lilly & Co. aims to offer a one-and-done heart-disease medicine by paying up to about $1.3 billion for Verve ...
Bloomberg journalists discuss today's biggest winners and losers in the stock market. Listen for analysis on the companies ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results